Dramatic response to albendazole in transplantation candidates with unresectable hepatic alveolar hydatid disease

Abstract

Abstract Long‐term albendazole treatment should be given to all patients with unresectable hepatic alveolar echinococcosis as dramatic regression is possible in 15%–20%. It may be prudent to prepare a living donor for possible salvage transplant in case of a severe complication. Preemptive transplantation in mildly symptomatic patients should be discouraged.

Keywords

• Albendazole
• alveolar hydatid
• dramatic regression
• Echinococcus multilocularis
• liver transplantation